2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tumor Multigene Detection Kit Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-4B15103
Home | Market Reports | Health| Health Conditions| Cancer
Global Tumor Multigene Detection Kit Market Research Report 2023
BUY CHAPTERS

Global Tumor Multigene Detection Kit Market Research Report 2025

Code: QYRE-Auto-4B15103
Report
May 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tumor Multigene Detection Kit Market Size

The global market for Tumor Multigene Detection Kit was valued at US$ 1163 million in the year 2024 and is projected to reach a revised size of US$ 3243 million by 2031, growing at a CAGR of 16.0% during the forecast period.

Tumor Multigene Detection Kit Market

Tumor Multigene Detection Kit Market

Tumor NGS detection kit is an experimental consumable used in tumor detection
North American market for Tumor Multigene Detection Kit is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tumor Multigene Detection Kit is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Tumor Multigene Detection Kit include Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine, NantHealth, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tumor Multigene Detection Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Multigene Detection Kit.
The Tumor Multigene Detection Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Multigene Detection Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Multigene Detection Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tumor Multigene Detection Kit Market Report

Report Metric Details
Report Name Tumor Multigene Detection Kit Market
Accounted market size in year US$ 1163 million
Forecasted market size in 2031 US$ 3243 million
CAGR 16.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Reversible End Termination Sequencing
  • Semiconductor Sequencing
  • Combined Probe Anchored Polymerization Sequencing
Segment by Application
  • Companion Diagnostics
  • Early Cancer Screening
  • Drug Discovery
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine, NantHealth, Personal Genome Diagnostics, GTH.O
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tumor Multigene Detection Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tumor Multigene Detection Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Tumor Multigene Detection Kit Market growing?

Ans: The Tumor Multigene Detection Kit Market witnessing a CAGR of 16.0% during the forecast period 2025-2031.

What is the Tumor Multigene Detection Kit Market size in 2031?

Ans: The Tumor Multigene Detection Kit Market size in 2031 will be US$ 3243 million.

Who are the main players in the Tumor Multigene Detection Kit Market report?

Ans: The main players in the Tumor Multigene Detection Kit Market are Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine, NantHealth, Personal Genome Diagnostics, GTH.O

What are the Application segmentation covered in the Tumor Multigene Detection Kit Market report?

Ans: The Applications covered in the Tumor Multigene Detection Kit Market report are Companion Diagnostics, Early Cancer Screening, Drug Discovery, Other

What are the Type segmentation covered in the Tumor Multigene Detection Kit Market report?

Ans: The Types covered in the Tumor Multigene Detection Kit Market report are Reversible End Termination Sequencing, Semiconductor Sequencing, Combined Probe Anchored Polymerization Sequencing

1 Tumor Multigene Detection Kit Market Overview
1.1 Product Definition
1.2 Tumor Multigene Detection Kit by Type
1.2.1 Global Tumor Multigene Detection Kit Market Value Comparison by Type (2024 VS 2031)
1.2.2 Reversible End Termination Sequencing
1.2.3 Semiconductor Sequencing
1.2.4 Combined Probe Anchored Polymerization Sequencing
1.3 Tumor Multigene Detection Kit by Application
1.3.1 Global Tumor Multigene Detection Kit Market Value by Application (2024 VS 2031)
1.3.2 Companion Diagnostics
1.3.3 Early Cancer Screening
1.3.4 Drug Discovery
1.3.5 Other
1.4 Global Tumor Multigene Detection Kit Market Size Estimates and Forecasts
1.4.1 Global Tumor Multigene Detection Kit Revenue 2020-2031
1.4.2 Global Tumor Multigene Detection Kit Sales 2020-2031
1.4.3 Global Tumor Multigene Detection Kit Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tumor Multigene Detection Kit Market Competition by Manufacturers
2.1 Global Tumor Multigene Detection Kit Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tumor Multigene Detection Kit Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tumor Multigene Detection Kit Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tumor Multigene Detection Kit, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tumor Multigene Detection Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tumor Multigene Detection Kit, Product Type & Application
2.7 Global Key Manufacturers of Tumor Multigene Detection Kit, Date of Enter into This Industry
2.8 Global Tumor Multigene Detection Kit Market Competitive Situation and Trends
2.8.1 Global Tumor Multigene Detection Kit Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tumor Multigene Detection Kit Players Market Share by Revenue
2.8.3 Global Tumor Multigene Detection Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tumor Multigene Detection Kit Market Scenario by Region
3.1 Global Tumor Multigene Detection Kit Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tumor Multigene Detection Kit Sales by Region: 2020-2031
3.2.1 Global Tumor Multigene Detection Kit Sales by Region: 2020-2025
3.2.2 Global Tumor Multigene Detection Kit Sales by Region: 2026-2031
3.3 Global Tumor Multigene Detection Kit Revenue by Region: 2020-2031
3.3.1 Global Tumor Multigene Detection Kit Revenue by Region: 2020-2025
3.3.2 Global Tumor Multigene Detection Kit Revenue by Region: 2026-2031
3.4 North America Tumor Multigene Detection Kit Market Facts & Figures by Country
3.4.1 North America Tumor Multigene Detection Kit Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tumor Multigene Detection Kit Sales by Country (2020-2031)
3.4.3 North America Tumor Multigene Detection Kit Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tumor Multigene Detection Kit Market Facts & Figures by Country
3.5.1 Europe Tumor Multigene Detection Kit Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tumor Multigene Detection Kit Sales by Country (2020-2031)
3.5.3 Europe Tumor Multigene Detection Kit Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tumor Multigene Detection Kit Market Facts & Figures by Region
3.6.1 Asia Pacific Tumor Multigene Detection Kit Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tumor Multigene Detection Kit Sales by Region (2020-2031)
3.6.3 Asia Pacific Tumor Multigene Detection Kit Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tumor Multigene Detection Kit Market Facts & Figures by Country
3.7.1 Latin America Tumor Multigene Detection Kit Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tumor Multigene Detection Kit Sales by Country (2020-2031)
3.7.3 Latin America Tumor Multigene Detection Kit Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tumor Multigene Detection Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Tumor Multigene Detection Kit Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tumor Multigene Detection Kit Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tumor Multigene Detection Kit Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tumor Multigene Detection Kit Sales by Type (2020-2031)
4.1.1 Global Tumor Multigene Detection Kit Sales by Type (2020-2025)
4.1.2 Global Tumor Multigene Detection Kit Sales by Type (2026-2031)
4.1.3 Global Tumor Multigene Detection Kit Sales Market Share by Type (2020-2031)
4.2 Global Tumor Multigene Detection Kit Revenue by Type (2020-2031)
4.2.1 Global Tumor Multigene Detection Kit Revenue by Type (2020-2025)
4.2.2 Global Tumor Multigene Detection Kit Revenue by Type (2026-2031)
4.2.3 Global Tumor Multigene Detection Kit Revenue Market Share by Type (2020-2031)
4.3 Global Tumor Multigene Detection Kit Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tumor Multigene Detection Kit Sales by Application (2020-2031)
5.1.1 Global Tumor Multigene Detection Kit Sales by Application (2020-2025)
5.1.2 Global Tumor Multigene Detection Kit Sales by Application (2026-2031)
5.1.3 Global Tumor Multigene Detection Kit Sales Market Share by Application (2020-2031)
5.2 Global Tumor Multigene Detection Kit Revenue by Application (2020-2031)
5.2.1 Global Tumor Multigene Detection Kit Revenue by Application (2020-2025)
5.2.2 Global Tumor Multigene Detection Kit Revenue by Application (2026-2031)
5.2.3 Global Tumor Multigene Detection Kit Revenue Market Share by Application (2020-2031)
5.3 Global Tumor Multigene Detection Kit Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche Foundation Medicine
6.1.1 Roche Foundation Medicine Company Information
6.1.2 Roche Foundation Medicine Description and Business Overview
6.1.3 Roche Foundation Medicine Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Foundation Medicine Tumor Multigene Detection Kit Product Portfolio
6.1.5 Roche Foundation Medicine Recent Developments/Updates
6.2 Illumina Inc.
6.2.1 Illumina Inc. Company Information
6.2.2 Illumina Inc. Description and Business Overview
6.2.3 Illumina Inc. Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Illumina Inc. Tumor Multigene Detection Kit Product Portfolio
6.2.5 Illumina Inc. Recent Developments/Updates
6.3 Life Technologies Corporation
6.3.1 Life Technologies Corporation Company Information
6.3.2 Life Technologies Corporation Description and Business Overview
6.3.3 Life Technologies Corporation Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Life Technologies Corporation Tumor Multigene Detection Kit Product Portfolio
6.3.5 Life Technologies Corporation Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Company Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Thermo Fisher Scientific Tumor Multigene Detection Kit Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Memorial Sloan Kettering
6.5.1 Memorial Sloan Kettering Company Information
6.5.2 Memorial Sloan Kettering Description and Business Overview
6.5.3 Memorial Sloan Kettering Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Memorial Sloan Kettering Tumor Multigene Detection Kit Product Portfolio
6.5.5 Memorial Sloan Kettering Recent Developments/Updates
6.6 Novogene
6.6.1 Novogene Company Information
6.6.2 Novogene Description and Business Overview
6.6.3 Novogene Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novogene Tumor Multigene Detection Kit Product Portfolio
6.6.5 Novogene Recent Developments/Updates
6.7 Geneseeq
6.7.1 Geneseeq Company Information
6.7.2 Geneseeq Description and Business Overview
6.7.3 Geneseeq Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Geneseeq Tumor Multigene Detection Kit Product Portfolio
6.7.5 Geneseeq Recent Developments/Updates
6.8 AmoyDx
6.8.1 AmoyDx Company Information
6.8.2 AmoyDx Description and Business Overview
6.8.3 AmoyDx Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AmoyDx Tumor Multigene Detection Kit Product Portfolio
6.8.5 AmoyDx Recent Developments/Updates
6.9 Burning Rock Medicine
6.9.1 Burning Rock Medicine Company Information
6.9.2 Burning Rock Medicine Description and Business Overview
6.9.3 Burning Rock Medicine Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Burning Rock Medicine Tumor Multigene Detection Kit Product Portfolio
6.9.5 Burning Rock Medicine Recent Developments/Updates
6.10 NantHealth
6.10.1 NantHealth Company Information
6.10.2 NantHealth Description and Business Overview
6.10.3 NantHealth Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.10.4 NantHealth Tumor Multigene Detection Kit Product Portfolio
6.10.5 NantHealth Recent Developments/Updates
6.11 Personal Genome Diagnostics
6.11.1 Personal Genome Diagnostics Company Information
6.11.2 Personal Genome Diagnostics Description and Business Overview
6.11.3 Personal Genome Diagnostics Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Personal Genome Diagnostics Tumor Multigene Detection Kit Product Portfolio
6.11.5 Personal Genome Diagnostics Recent Developments/Updates
6.12 GTH.O
6.12.1 GTH.O Company Information
6.12.2 GTH.O Description and Business Overview
6.12.3 GTH.O Tumor Multigene Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.12.4 GTH.O Tumor Multigene Detection Kit Product Portfolio
6.12.5 GTH.O Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tumor Multigene Detection Kit Industry Chain Analysis
7.2 Tumor Multigene Detection Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tumor Multigene Detection Kit Production Mode & Process Analysis
7.4 Tumor Multigene Detection Kit Sales and Marketing
7.4.1 Tumor Multigene Detection Kit Sales Channels
7.4.2 Tumor Multigene Detection Kit Distributors
7.5 Tumor Multigene Detection Kit Customer Analysis
8 Tumor Multigene Detection Kit Market Dynamics
8.1 Tumor Multigene Detection Kit Industry Trends
8.2 Tumor Multigene Detection Kit Market Drivers
8.3 Tumor Multigene Detection Kit Market Challenges
8.4 Tumor Multigene Detection Kit Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Tumor Multigene Detection Kit Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Tumor Multigene Detection Kit Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Tumor Multigene Detection Kit Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Tumor Multigene Detection Kit Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Tumor Multigene Detection Kit Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Tumor Multigene Detection Kit Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Tumor Multigene Detection Kit Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Tumor Multigene Detection Kit Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Tumor Multigene Detection Kit, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Tumor Multigene Detection Kit, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Tumor Multigene Detection Kit, Product Type & Application
 Table 12. Global Key Manufacturers of Tumor Multigene Detection Kit, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Tumor Multigene Detection Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Multigene Detection Kit as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tumor Multigene Detection Kit Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Tumor Multigene Detection Kit Sales by Region (2020-2025) & (K Units)
 Table 18. Global Tumor Multigene Detection Kit Sales Market Share by Region (2020-2025)
 Table 19. Global Tumor Multigene Detection Kit Sales by Region (2026-2031) & (K Units)
 Table 20. Global Tumor Multigene Detection Kit Sales Market Share by Region (2026-2031)
 Table 21. Global Tumor Multigene Detection Kit Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Tumor Multigene Detection Kit Revenue Market Share by Region (2020-2025)
 Table 23. Global Tumor Multigene Detection Kit Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Tumor Multigene Detection Kit Revenue Market Share by Region (2026-2031)
 Table 25. North America Tumor Multigene Detection Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Tumor Multigene Detection Kit Sales by Country (2020-2025) & (K Units)
 Table 27. North America Tumor Multigene Detection Kit Sales by Country (2026-2031) & (K Units)
 Table 28. North America Tumor Multigene Detection Kit Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Tumor Multigene Detection Kit Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Tumor Multigene Detection Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Tumor Multigene Detection Kit Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Tumor Multigene Detection Kit Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Tumor Multigene Detection Kit Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Tumor Multigene Detection Kit Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Tumor Multigene Detection Kit Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Tumor Multigene Detection Kit Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Tumor Multigene Detection Kit Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Tumor Multigene Detection Kit Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Tumor Multigene Detection Kit Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tumor Multigene Detection Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Tumor Multigene Detection Kit Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Tumor Multigene Detection Kit Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Tumor Multigene Detection Kit Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Tumor Multigene Detection Kit Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Tumor Multigene Detection Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Tumor Multigene Detection Kit Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Tumor Multigene Detection Kit Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Tumor Multigene Detection Kit Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Tumor Multigene Detection Kit Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Tumor Multigene Detection Kit Sales (K Units) by Type (2020-2025)
 Table 51. Global Tumor Multigene Detection Kit Sales (K Units) by Type (2026-2031)
 Table 52. Global Tumor Multigene Detection Kit Sales Market Share by Type (2020-2025)
 Table 53. Global Tumor Multigene Detection Kit Sales Market Share by Type (2026-2031)
 Table 54. Global Tumor Multigene Detection Kit Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Tumor Multigene Detection Kit Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Tumor Multigene Detection Kit Revenue Market Share by Type (2020-2025)
 Table 57. Global Tumor Multigene Detection Kit Revenue Market Share by Type (2026-2031)
 Table 58. Global Tumor Multigene Detection Kit Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Tumor Multigene Detection Kit Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Tumor Multigene Detection Kit Sales (K Units) by Application (2020-2025)
 Table 61. Global Tumor Multigene Detection Kit Sales (K Units) by Application (2026-2031)
 Table 62. Global Tumor Multigene Detection Kit Sales Market Share by Application (2020-2025)
 Table 63. Global Tumor Multigene Detection Kit Sales Market Share by Application (2026-2031)
 Table 64. Global Tumor Multigene Detection Kit Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Tumor Multigene Detection Kit Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Tumor Multigene Detection Kit Revenue Market Share by Application (2020-2025)
 Table 67. Global Tumor Multigene Detection Kit Revenue Market Share by Application (2026-2031)
 Table 68. Global Tumor Multigene Detection Kit Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Tumor Multigene Detection Kit Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Foundation Medicine Company Information
 Table 71. Roche Foundation Medicine Description and Business Overview
 Table 72. Roche Foundation Medicine Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Foundation Medicine Tumor Multigene Detection Kit Product
 Table 74. Roche Foundation Medicine Recent Developments/Updates
 Table 75. Illumina Inc. Company Information
 Table 76. Illumina Inc. Description and Business Overview
 Table 77. Illumina Inc. Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Illumina Inc. Tumor Multigene Detection Kit Product
 Table 79. Illumina Inc. Recent Developments/Updates
 Table 80. Life Technologies Corporation Company Information
 Table 81. Life Technologies Corporation Description and Business Overview
 Table 82. Life Technologies Corporation Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Life Technologies Corporation Tumor Multigene Detection Kit Product
 Table 84. Life Technologies Corporation Recent Developments/Updates
 Table 85. Thermo Fisher Scientific Company Information
 Table 86. Thermo Fisher Scientific Description and Business Overview
 Table 87. Thermo Fisher Scientific Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Thermo Fisher Scientific Tumor Multigene Detection Kit Product
 Table 89. Thermo Fisher Scientific Recent Developments/Updates
 Table 90. Memorial Sloan Kettering Company Information
 Table 91. Memorial Sloan Kettering Description and Business Overview
 Table 92. Memorial Sloan Kettering Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Memorial Sloan Kettering Tumor Multigene Detection Kit Product
 Table 94. Memorial Sloan Kettering Recent Developments/Updates
 Table 95. Novogene Company Information
 Table 96. Novogene Description and Business Overview
 Table 97. Novogene Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Novogene Tumor Multigene Detection Kit Product
 Table 99. Novogene Recent Developments/Updates
 Table 100. Geneseeq Company Information
 Table 101. Geneseeq Description and Business Overview
 Table 102. Geneseeq Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Geneseeq Tumor Multigene Detection Kit Product
 Table 104. Geneseeq Recent Developments/Updates
 Table 105. AmoyDx Company Information
 Table 106. AmoyDx Description and Business Overview
 Table 107. AmoyDx Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. AmoyDx Tumor Multigene Detection Kit Product
 Table 109. AmoyDx Recent Developments/Updates
 Table 110. Burning Rock Medicine Company Information
 Table 111. Burning Rock Medicine Description and Business Overview
 Table 112. Burning Rock Medicine Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Burning Rock Medicine Tumor Multigene Detection Kit Product
 Table 114. Burning Rock Medicine Recent Developments/Updates
 Table 115. NantHealth Company Information
 Table 116. NantHealth Description and Business Overview
 Table 117. NantHealth Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. NantHealth Tumor Multigene Detection Kit Product
 Table 119. NantHealth Recent Developments/Updates
 Table 120. Personal Genome Diagnostics Company Information
 Table 121. Personal Genome Diagnostics Description and Business Overview
 Table 122. Personal Genome Diagnostics Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Personal Genome Diagnostics Tumor Multigene Detection Kit Product
 Table 124. Personal Genome Diagnostics Recent Developments/Updates
 Table 125. GTH.O Company Information
 Table 126. GTH.O Description and Business Overview
 Table 127. GTH.O Tumor Multigene Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. GTH.O Tumor Multigene Detection Kit Product
 Table 129. GTH.O Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Tumor Multigene Detection Kit Distributors List
 Table 133. Tumor Multigene Detection Kit Customers List
 Table 134. Tumor Multigene Detection Kit Market Trends
 Table 135. Tumor Multigene Detection Kit Market Drivers
 Table 136. Tumor Multigene Detection Kit Market Challenges
 Table 137. Tumor Multigene Detection Kit Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tumor Multigene Detection Kit
 Figure 2. Global Tumor Multigene Detection Kit Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tumor Multigene Detection Kit Market Share by Type: 2024 & 2031
 Figure 4. Reversible End Termination Sequencing Product Picture
 Figure 5. Semiconductor Sequencing Product Picture
 Figure 6. Combined Probe Anchored Polymerization Sequencing Product Picture
 Figure 7. Global Tumor Multigene Detection Kit Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Tumor Multigene Detection Kit Market Share by Application: 2024 & 2031
 Figure 9. Companion Diagnostics
 Figure 10. Early Cancer Screening
 Figure 11. Drug Discovery
 Figure 12. Other
 Figure 13. Global Tumor Multigene Detection Kit Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Tumor Multigene Detection Kit Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Tumor Multigene Detection Kit Sales (2020-2031) & (K Units)
 Figure 16. Global Tumor Multigene Detection Kit Average Price (US$/Unit) & (2020-2031)
 Figure 17. Tumor Multigene Detection Kit Report Years Considered
 Figure 18. Tumor Multigene Detection Kit Sales Share by Manufacturers in 2024
 Figure 19. Global Tumor Multigene Detection Kit Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Tumor Multigene Detection Kit Players: Market Share by Revenue in Tumor Multigene Detection Kit in 2024
 Figure 21. Tumor Multigene Detection Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Tumor Multigene Detection Kit Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Tumor Multigene Detection Kit Sales Market Share by Country (2020-2031)
 Figure 24. North America Tumor Multigene Detection Kit Revenue Market Share by Country (2020-2031)
 Figure 25. United States Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Tumor Multigene Detection Kit Sales Market Share by Country (2020-2031)
 Figure 28. Europe Tumor Multigene Detection Kit Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Tumor Multigene Detection Kit Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Tumor Multigene Detection Kit Revenue Market Share by Region (2020-2031)
 Figure 36. China Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Tumor Multigene Detection Kit Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Tumor Multigene Detection Kit Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Tumor Multigene Detection Kit Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Tumor Multigene Detection Kit Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Tumor Multigene Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Tumor Multigene Detection Kit by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Tumor Multigene Detection Kit by Type (2020-2031)
 Figure 55. Global Tumor Multigene Detection Kit Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Tumor Multigene Detection Kit by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Tumor Multigene Detection Kit by Application (2020-2031)
 Figure 58. Global Tumor Multigene Detection Kit Price (US$/Unit) by Application (2020-2031)
 Figure 59. Tumor Multigene Detection Kit Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart